Hong Fang Song - Aug 29, 2024 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Role
Director
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for Hong Fang Song
Stock symbol
CGON
Transactions as of
Aug 29, 2024
Transactions value $
-$23,000,089
Form type
4
Date filed
8/30/2024, 07:18 PM
Previous filing
Jan 31, 2024
Next filing
Oct 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGON Common Stock Sale -$15M -424K -41.95% $35.36 587K Aug 29, 2024 By Unique Diamond Investments Limited F1, F2
transaction CGON Common Stock Sale -$8M -226K -5.76% $35.36 3.7M Aug 29, 2024 By Charming Jade Limited F2, F3
holding CGON Common Stock 614K Aug 29, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P.
F2 Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.
F3 Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P.